Biofrontera Inc. Operating Lease Right-of-Use Assets
Biofrontera Inc. (BFRI) had Operating Lease Right-of-Use Assets of $2.81 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-13
- 2026-06-30: Operating Lease, Right-of-Use Asset $2.81M.
- 2026-03-31: Operating Lease, Right-of-Use Asset $2.90M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $1.58M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $488.00K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $2.81M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $2.90M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $1.58M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $488.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $729.00K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $713.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $903.00K 10-K · filed 2026-03-19 |
| 2024-09-30 | $1.08M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $1.23M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $1.42M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $1.61M 10-K · filed 2025-03-20 |
| 2023-09-30 | $1.13M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $1.11M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $1.23M 10-Q · filed 2023-05-12 |
| 2023-01-01 | $1.80M 10-K · filed 2025-03-20 |
| 2022-12-31 | $1.38M 10-K · filed 2024-03-15 |
| 2022-01-01 | $1.80M 10-K · filed 2024-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |